DCM
MRNA icon

Driehaus Capital Management’s Moderna MRNA Stock Holding History

Driehaus Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-19,776
Closed -$7.61M – 421
2021
Q3 		$7.61M Buy
19,776
+16,555
+514% +$6.11M 0.09% 268
2021
Q2 		$757K Buy
3,221
+1,052
+49% +$188K 0.01% 357
2021
Q1 		$284K Buy
2,169
+164
+8% +$23.8K ﹤0.01% 418
2020
Q4 		$209K Sell
2,005
-1,773
-47% -$179K ﹤0.01% 411
2020
Q3 		$267K Buy
3,778
+462
+14% +$32.2K 0.01% 369
2020
Q2 		$213K Buy
+3,316
New +$182K 0.01% 363

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Driehaus Capital Management's MRNA Position: Q4 2021 in Review

Driehaus Capital Management sold out of Moderna (MRNA) in Q4 2021, closing a stake of 19,776 shares — an estimated $7.61M sold.

Driehaus Capital Management first reported a position in MRNA in Q2 2020 and held it in 6 quarters. The position peaked at $7.61M in Q3 2021. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Driehaus Capital Management reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • Driehaus Capital Management sold 19,776 Moderna shares in Q4 2021, an estimated $7.61M.
  • Driehaus Capital Management first reported a position in Moderna in Q2 2020 and held it in 6 quarters.
  • Driehaus Capital Management's Moderna position peaked at $7.61M in Q3 2021.
  • 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Driehaus Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.